Klaipedos universiteto ligonine VšĮ

Klaipedos universiteto ligonine VšĮ is conducting research in the field of cardiovascular diseases, targeting the prevention of stroke and systemic embolism in patients with atrial fibrillation. The studies compare innovative oral anticoagulants to standard therapy to determine safety and benefit.

• Long‑term safety profile of a novel anticoagulant compared with established treatment
• Efficacy of asundexian in reducing stroke risk in atrial fibrillation
• Evaluation of major bleeding outcomes using ISTH criteria

A team of 19 investigators supports these two cardiovascular trials, contributing to improved treatment options for at‑risk patients.

Research at the hospital also addresses digestive system diseases, with a focus on ulcerative colitis. The goal is to determine whether new therapeutic agents provide lasting remission and safety for patients.

• Long‑term efficacy of ABT‑494 in maintaining ulcerative colitis remission
• Safety monitoring of chronic therapy in inflammatory bowel disease
• Impact on quality of life and disease activity scores

These two trials involve the same group of investigators, reflecting the site’s commitment to advancing care in both cardiovascular and gastrointestinal fields.